Evidence map›Paper›PMID 39730921›Full record

ArticleScientific reports2024

Impact of platelet-lymphocyte ratio after robot-assisted partial nephrectomy with renorrhaphy.

Tomoki Taniguchi, Kentaro Muraoka, Kohei Nishikawa, Yoshinori Ikehata, Kiyoshi Setoguchi, Suguru Oka, Shin Ebara, Akira Fujisaki, Kazuhide Makiyama, Takahiro Inoue and 5 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Tomoki TaniguchiDepartment of Urology, Graduate School of Medicine, Gifu University, 1-1 Yanagido, Gifu, 501-1194, Japan.
Kentaro MuraokaDepartment of Urology, Graduate School of Medicine, Yokohama City University, Yokohama, Japan.
Kohei NishikawaDepartment of Urology, Graduate School of Medicine, Mie University, Tsu, Japan.
Yoshinori IkehataDepartment of Urology, Graduate School of Medicine, Toyama University, Toyama, Japan.
Kiyoshi SetoguchiDepartment of Urology, Dokkyo Medical University Saitama Medical Center, Koshigaya, Japan.
Suguru OkaDepartment of Urology, Toranomon Hospital, Tokyo, Japan.
Shin EbaraDepartment of Urology, Hiroshima City Hiroshima Citizens Hospital, Hiroshima, Japan.
Akira FujisakiDepartment of Urology, Seirei Hamamatsu General Hospital, Hamamatsu, Japan.
Kazuhide MakiyamaDepartment of Urology, Graduate School of Medicine, Yokohama City University, Yokohama, Japan.
Takahiro InoueDepartment of Urology, Graduate School of Medicine, Mie University, Tsu, Japan.
Hiroshi KitamuraDepartment of Urology, Graduate School of Medicine, Toyama University, Toyama, Japan.
Kazutaka SaitoDepartment of Urology, Dokkyo Medical University Saitama Medical Center, Koshigaya, Japan.
Shinji UrakamiDepartment of Urology, Toranomon Hospital, Tokyo, Japan.
Tatsuaki YonedaDepartment of Urology, Seirei Hamamatsu General Hospital, Hamamatsu, Japan.
Takuya KoieDepartment of Urology, Graduate School of Medicine, Gifu University, 1-1 Yanagido, Gifu, 501-1194, Japan. koie.takuya.h2@f.gifu-u.ac.jp.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Renorrhaphy is often performed after tumor resection during robotic-assisted laparoscopic partial nephrectomy (RAPN). This study aimed to investigate the association between renorrhaphy performance and inflammatory markers. A retrospective cohort study was conducted including patients with renal cell carcinoma who underwent RAPN at eight institutions in Japan between April 2016 and November 2023. The primary endpoint was the association between the renorrhaphy performance in RAPN and the postoperative inflammatory markers. The secondary endpoints were perioperative outcomes in patients with and without renorrhaphy. The patients were divided into two groups at the time of RAPN: those who underwent renorrhaphy (renorrhaphy group) and those who did not (omitted group). In total, 934 patients were enrolled in this study. After propensity score matching, the rate of change in C-reactive protein and neutrophil-lymphocyte ratio on postoperative day 28 were not significant difference between the two groups. In contrast, the rate of change in platelet-lymphocyte ratio (PLR) on postoperative day 28 was significantly higher in renorrhaphy group than omitted group. Regarding surgical outcomes, the renorrhaphy group had a significantly longer hospital stay, operative time, and warm ischemia time (P = 0.038, P = 0.022, and P = 0.009, respectively) than the omitted group did. Furthermore, the omitted group had a significantly higher rate of Trifecta achievement than the renorrhaphy group did. This study demonstrated that renorrhaphy performance in RAPN was significantly associated with the higher value of postoperative PLR.

Indexed as

Blood PlateletsKidney NeoplasmsNephrectomyRobotic Surgical ProceduresAgedCarcinoma, Renal CellFemaleHumansJapanLaparoscopyLength of StayLymphocyte CountLymphocytesMaleMiddle AgedOperative TimePlatelet-to-lymphocyte ratioRenal cell carcinomaRenorrhaphyRobot-assisted partial nephrectomy

Identifiers

PMID39730921
PMCPMC11680792

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.